Koyfin Home > Directory > Health Care > Aldeyra Therapeu > EBITDA / Interest Expenses

Aldeyra Therapeu EBITDA / Interest Expenses Chart (ALDX)

Aldeyra Therapeu annual/quarterly EBITDA / Interest Expenses from 2012 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Aldeyra Therapeu EBITDA / Interest Expenses for the quarter ending June 06, 2020 was $-14m a -4,432.75% increase of 637m year over year
  • Aldeyra Therapeu EBITDA / Interest Expenses for the last 12 months ending June 06, 2020 was $-32m a -1,272.65% increase of 410m year over year
  • Aldeyra Therapeu Annual EBITDA / Interest Expenses for 2019 was $-93m a -190.06% increase of 177m from 2018
  • Aldeyra Therapeu Annual EBITDA / Interest Expenses for 2018 was $-270m a 26.70% decrease of -72m from 2017
  • Aldeyra Therapeu Annual EBITDA / Interest Expenses for 2017 was $-198m a 10.63% decrease of -21m from 2016
Other Ratios Metrics:
  • Aldeyra Therapeu Total Debt / Capital for the quarter ending September 09, 2018 was $5m a 27.49% increase of 1m year over year
  • Aldeyra Therapeu Other Liabilities for the quarter ending March 03, 2014 was $1m
  • Aldeyra Therapeu Total Debt / Equity for the quarter ending September 09, 2018 was $5m a 28.41% increase of 1m year over year
View Chart On Koyfin

Quarterly ALDX EBITDA / Interest Expenses Data

06/2020$-14m
03/2020$-22m
12/2019$-23m
09/2019$-651m
06/2019$-478m
03/2019$-5,482m
12/2018$-174m
09/2018$-379m
06/2018$-347m
03/2018$-302m

Annual ALDX EBITDA / Interest Expenses Data

2019$-93m
2018$-270m
2017$-198m
2016$-177m
2015$-107m
2014$-30m
2013$-23m
2012$-3m
2011$-8m